SQUID(protocol/trial thatsupported theaddition of SQinsulin in themagangement ofmild DKA)<6.9 (pH cutoff for routineadministrationof sodiumbicarb)1 (units/mL;standardconcentrationof IV insulininfusion)Infection (driverof DKA outsideof noncompliance andnew diagnosis)3.3 (mimimummEq/L K shouldbe prior toinitiated insulininfusion)<7.3 (pHcriteria forDKAdiagnosis)Polydipsia, polyphagia,polyuria (hallmarksymptoms ofuncontrolled/undiagnosedDM)IV (should only be usedfor patients withDKA/HHS/Hyperkalemia)20 (# mEq of Kthat should beadded to eachliter withconcurrentinsulin infusion)320 (Totalserumomolarity cutoff for HHS)Kussmals(types ofrespirationsassociatedwith DKA)0.1 (units/kg/hrfor nonglucommanderDKA/HHS)250 (BGL cutoff to startaddingdextrose tofluids in DKA)Awiqli(newest FDAapprovedinsulin)0.5(units/kg/day;recommendstarting dosefor new startinsulin)300 (BGL cutoff to startaddingdextrose tofluids in HHS)Basal(anotherterm for longactinginsulin)Cerebral Edema(complication ofrapidly decreasingBGL in HHSpatients (primarilyin the young)Lactic acidosis(possiblecomplication ofhallmark DMoral therapy)Euglycemic(Type of DKAthat can be anadverse eventwith use ofSGLT2s)Fluids (mostimportant initialtreatment inhyperglycemicemergencies)50 (averagemg/dL drop inBGL per 1unit rapidacting insulin)BHG (replacedAG asdiagnosticcriteria in latestDKA/HHSguidelines)LR (fluidchoiced forfasterresolution ofacidosis inDKA)Octerotide(medicationthat be usedin SU/insulinoverdose)6.5 (A1CDMdiagnosticcriteria)600 (BGL levelwith HHS glucosediagnosticcriteria/max MHSglucommanderreading)126(FastingBGL for DMdiagnosis)SQUID(protocol/trial thatsupported theaddition of SQinsulin in themagangement ofmild DKA)<6.9 (pH cutoff for routineadministrationof sodiumbicarb)1 (units/mL;standardconcentrationof IV insulininfusion)Infection (driverof DKA outsideof noncompliance andnew diagnosis)3.3 (mimimummEq/L K shouldbe prior toinitiated insulininfusion)<7.3 (pHcriteria forDKAdiagnosis)Polydipsia, polyphagia,polyuria (hallmarksymptoms ofuncontrolled/undiagnosedDM)IV (should only be usedfor patients withDKA/HHS/Hyperkalemia)20 (# mEq of Kthat should beadded to eachliter withconcurrentinsulin infusion)320 (Totalserumomolarity cutoff for HHS)Kussmals(types ofrespirationsassociatedwith DKA)0.1 (units/kg/hrfor nonglucommanderDKA/HHS)250 (BGL cutoff to startaddingdextrose tofluids in DKA)Awiqli(newest FDAapprovedinsulin)0.5(units/kg/day;recommendstarting dosefor new startinsulin)300 (BGL cutoff to startaddingdextrose tofluids in HHS)Basal(anotherterm for longactinginsulin)Cerebral Edema(complication ofrapidly decreasingBGL in HHSpatients (primarilyin the young)Lactic acidosis(possiblecomplication ofhallmark DMoral therapy)Euglycemic(Type of DKAthat can be anadverse eventwith use ofSGLT2s)Fluids (mostimportant initialtreatment inhyperglycemicemergencies)50 (averagemg/dL drop inBGL per 1unit rapidacting insulin)BHG (replacedAG asdiagnosticcriteria in latestDKA/HHSguidelines)LR (fluidchoiced forfasterresolution ofacidosis inDKA)Octerotide(medicationthat be usedin SU/insulinoverdose)6.5 (A1CDMdiagnosticcriteria)600 (BGL levelwith HHS glucosediagnosticcriteria/max MHSglucommanderreading)126(FastingBGL for DMdiagnosis)

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
  1. SQUID (protocol/trial that supported the addition of SQ insulin in the magangement of mild DKA)
  2. <6.9 (pH cut off for routine administration of sodium bicarb)
  3. 1 (units/mL; standard concentration of IV insulin infusion)
  4. Infection (driver of DKA outside of non compliance and new diagnosis)
  5. 3.3 (mimimum mEq/L K should be prior to initiated insulin infusion)
  6. <7.3 (pH criteria for DKA diagnosis)
  7. Polydipsia, polyphagia, polyuria (hallmark symptoms of uncontrolled/undiagnosed DM)
  8. IV (should only be used for patients with DKA/HHS/Hyperkalemia)
  9. 20 (# mEq of K that should be added to each liter with concurrent insulin infusion)
  10. 320 (Total serum omolarity cut off for HHS)
  11. Kussmals (types of respirations associated with DKA)
  12. 0.1 (units/kg/hr for non glucommander DKA/HHS)
  13. 250 (BGL cut off to start adding dextrose to fluids in DKA)
  14. Awiqli (newest FDA approved insulin)
  15. 0.5 (units/kg/day; recommend starting dose for new start insulin)
  16. 300 (BGL cut off to start adding dextrose to fluids in HHS)
  17. Basal (another term for long acting insulin)
  18. Cerebral Edema (complication of rapidly decreasing BGL in HHS patients (primarily in the young)
  19. Lactic acidosis (possible complication of hallmark DM oral therapy)
  20. Euglycemic (Type of DKA that can be an adverse event with use of SGLT2s)
  21. Fluids (most important initial treatment in hyperglycemic emergencies)
  22. 50 (average mg/dL drop in BGL per 1 unit rapid acting insulin)
  23. BHG (replaced AG as diagnostic criteria in latest DKA/HHS guidelines)
  24. LR (fluid choiced for faster resolution of acidosis in DKA)
  25. Octerotide (medication that be used in SU/insulin overdose)
  26. 6.5 (A1C DM diagnostic criteria)
  27. 600 (BGL level with HHS glucose diagnostic criteria/max MHS glucommander reading)
  28. 126 (Fasting BGL for DM diagnosis)